Conventional and Novel Approaches to Immunosuppression

Timothy Floreth, Sangeeta M. Bhorade, Vivek N. Ahya*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Immunosuppressive therapy has contributed significantly to improved survival after solid organ transplantation. Nevertheless, treatment-related adverse events and persistently high risk of chronic graft rejection remain major obstacles to long-term survival after lung transplantation. The development of new agents, refinements in techniques to monitor immunosuppression, and enhanced understanding of transplant immunobiology are essential for further improvements in outcome. In this article, conventional immunosuppressive regimens, novel approaches to preventing graft rejection, and investigational agents for solid organ transplantation are reviewed.

Original languageEnglish (US)
Pages (from-to)265-277
Number of pages13
JournalClinics in Chest Medicine
Issue number2
StatePublished - Jun 2011


  • Immunosuppression
  • Induction therapy
  • Lung transplantation
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Conventional and Novel Approaches to Immunosuppression'. Together they form a unique fingerprint.

Cite this